JP2008526936A5 - - Google Patents

Download PDF

Info

Publication number
JP2008526936A5
JP2008526936A5 JP2007550831A JP2007550831A JP2008526936A5 JP 2008526936 A5 JP2008526936 A5 JP 2008526936A5 JP 2007550831 A JP2007550831 A JP 2007550831A JP 2007550831 A JP2007550831 A JP 2007550831A JP 2008526936 A5 JP2008526936 A5 JP 2008526936A5
Authority
JP
Japan
Prior art keywords
efficient
developed
series
treatment
discloses
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2007550831A
Other languages
English (en)
Japanese (ja)
Other versions
JP2008526936A (ja
Filing date
Publication date
Priority claimed from GBGB0500604.4A external-priority patent/GB0500604D0/en
Application filed filed Critical
Publication of JP2008526936A publication Critical patent/JP2008526936A/ja
Publication of JP2008526936A5 publication Critical patent/JP2008526936A5/ja
Pending legal-status Critical Current

Links

JP2007550831A 2005-01-13 2006-01-09 置換インドールの新規製造方法 Pending JP2008526936A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0500604.4A GB0500604D0 (en) 2005-01-13 2005-01-13 Novel process
PCT/GB2006/000060 WO2006075139A2 (en) 2005-01-13 2006-01-09 Novel process for the preparation of substituted indoles

Publications (2)

Publication Number Publication Date
JP2008526936A JP2008526936A (ja) 2008-07-24
JP2008526936A5 true JP2008526936A5 (https=) 2009-02-12

Family

ID=34203986

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2007550831A Pending JP2008526936A (ja) 2005-01-13 2006-01-09 置換インドールの新規製造方法

Country Status (15)

Country Link
US (1) US7781598B2 (https=)
EP (1) EP1844012A2 (https=)
JP (1) JP2008526936A (https=)
KR (1) KR20070104350A (https=)
CN (1) CN101102999B (https=)
AU (1) AU2006205697B2 (https=)
BR (1) BRPI0606639A2 (https=)
CA (1) CA2594391A1 (https=)
GB (1) GB0500604D0 (https=)
IL (1) IL183965A0 (https=)
MX (1) MX2007008348A (https=)
NO (1) NO20074047L (https=)
NZ (1) NZ556147A (https=)
WO (1) WO2006075139A2 (https=)
ZA (1) ZA200705216B (https=)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW200307542A (en) 2002-05-30 2003-12-16 Astrazeneca Ab Novel compounds
SE0202241D0 (sv) * 2002-07-17 2002-07-17 Astrazeneca Ab Novel Compounds
SE0301569D0 (sv) * 2003-05-27 2003-05-27 Astrazeneca Ab Novel compounds
SE0302232D0 (sv) * 2003-08-18 2003-08-18 Astrazeneca Ab Novel Compounds
SE0303180D0 (sv) * 2003-11-26 2003-11-26 Astrazeneca Ab Novel compounds
GB0500604D0 (en) 2005-01-13 2005-02-16 Astrazeneca Ab Novel process
CN101454284A (zh) * 2006-05-26 2009-06-10 阿斯利康(瑞典)有限公司 联芳基或芳基-杂芳基取代的吲哚类化合物
CA2767132C (en) 2009-07-06 2017-06-20 Astrazeneca Ab Intermediates and processes for the preparation of 4-(acetylamino))-3-[(4-chloro-phenyl)thio]-2-methyl-1h-indole-1-acetic acid
EP2790696A1 (en) 2011-12-16 2014-10-22 Atopix Therapeutics Limited Combination of crth2 antagonist and a proton pump inhibitor for the treatment of eosinophilic esophagitis
CN103288707B (zh) * 2013-05-28 2015-12-23 浙江大学 一种3-苯巯基吲哚衍生物的制备方法

Family Cites Families (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE790679A (fr) 1971-11-03 1973-04-27 Ici Ltd Derives de l'indole
JPH0615542B2 (ja) 1986-07-22 1994-03-02 吉富製薬株式会社 ピラゾロピリジン化合物
US5095031A (en) * 1990-08-20 1992-03-10 Abbott Laboratories Indole derivatives which inhibit leukotriene biosynthesis
WO1993005020A1 (en) 1991-09-06 1993-03-18 Merck & Co., Inc. Indoles as inhibitors of hiv reverse transcriptase
FR2692574B1 (fr) 1992-06-23 1995-06-23 Sanofi Elf Derives hydroxy-4 benzenethio, leur preparation ainsi que leur utilisation pour la preparation de derives aminoalkoxybenzenesulfonyles.
HUT74614A (en) 1993-02-24 1997-01-28 Merck & Co Inc Nindol derivates suitable for treatment of infection by hiv and pharmaceutical compositions containing them
US5486525A (en) 1993-12-16 1996-01-23 Abbott Laboratories Platelet activating factor antagonists: imidazopyridine indoles
US5567711A (en) * 1995-04-19 1996-10-22 Abbott Laboratories Indole-3-carbonyl and indole-3-sulfonyl derivatives as platelet activating factor antagonists
TW472045B (en) 1996-09-25 2002-01-11 Astra Ab Protein kinase C inhibitor compounds, method for their preparation, pharmaceutical composition thereof and intermediate used for their preparation
AR017256A1 (es) 1997-08-21 2001-09-05 American Home Prod Compuestos de indol sustituidos, metodo para la sintesis en fase solida de los mismos, conjuntos de combinacion para ser empleados en dicho metodo, uso delos compuestos para preparar un medicamento y composiciones farmaceuticas que los comprenden
DE69814012T2 (de) 1997-12-19 2004-04-01 Eli Lilly And Co., Indianapolis Hypoglykàmische imidazoline derivate
US6916841B2 (en) * 1998-02-25 2005-07-12 Genetics Institute, Llc Inhibitors of phospholipase enzymes
AU5886500A (en) 1999-06-23 2001-01-09 Sepracor, Inc. Indolyl-benzimidazole antibacterials, and methods of use thereof
AU7962200A (en) 1999-10-29 2001-05-14 Wakunaga Pharmaceutical Co., Ltd Novel indole derivatives and drugs containing the same as the active ingredient
OA12514A (en) 1999-12-24 2006-05-29 Aventis Pharma Ltd Azaindoles.
NZ522074A (en) 2000-05-31 2004-06-25 Astrazeneca Ab Indole derivatives with vascular damaging activity
US6878522B2 (en) 2000-07-07 2005-04-12 Baiyong Li Methods for the identification of compounds useful for the treatment of disease states mediated by prostaglandin D2
WO2003013510A1 (en) * 2001-08-07 2003-02-20 Smithkline Beecham P.L.C. 3-arylsulfonyl-7-piperazinyl- indoles, -benzofurans and -benzothiophenes with 5-ht6 receptor affinity for treating cns disorders
TWI317634B (en) * 2001-12-13 2009-12-01 Nat Health Research Institutes Aroyl indoles compounds
CA2473803A1 (en) 2002-02-01 2003-08-07 Robert Greenhouse Substituted indoles as alpha-1 agonists
SE0200411D0 (sv) 2002-02-05 2002-02-05 Astrazeneca Ab Novel use
SE0200356D0 (sv) 2002-02-05 2002-02-05 Astrazeneca Ab Novel use
EP2423190A1 (en) 2002-05-16 2012-02-29 Shionogi&Co., Ltd. Compounds Exhibiting PGD 2 Receptor Antagonism
SE0201635D0 (sv) * 2002-05-30 2002-05-30 Astrazeneca Ab Novel compounds
TW200307542A (en) * 2002-05-30 2003-12-16 Astrazeneca Ab Novel compounds
SE0202241D0 (sv) * 2002-07-17 2002-07-17 Astrazeneca Ab Novel Compounds
SE0202463D0 (sv) 2002-08-14 2002-08-14 Astrazeneca Ab Novel compounds
EP1558614B1 (en) * 2002-10-30 2010-09-01 Merck Frosst Canada Ltd. Pyridopyrrolizine and pyridoindolizine derivatives
KR100755580B1 (ko) * 2002-12-03 2007-09-06 에프. 호프만-라 로슈 아게 Cns-장애의 치료를 위한 5-ht6-수용체 리간드로서의아미노알콕시인돌
SE0301569D0 (sv) * 2003-05-27 2003-05-27 Astrazeneca Ab Novel compounds
SE0302232D0 (sv) 2003-08-18 2003-08-18 Astrazeneca Ab Novel Compounds
AU2004283139A1 (en) 2003-10-14 2005-05-06 Oxagen Limited Compounds having CRTH2 antagonist activity
SE0303180D0 (sv) * 2003-11-26 2003-11-26 Astrazeneca Ab Novel compounds
GB0500604D0 (en) 2005-01-13 2005-02-16 Astrazeneca Ab Novel process
GB2422831A (en) 2005-02-04 2006-08-09 Oxagen Ltd Pyrrolopyridines and their use in the treatment of diseases mediated by PGD2 at the CRTH2 receptor
CN101454284A (zh) * 2006-05-26 2009-06-10 阿斯利康(瑞典)有限公司 联芳基或芳基-杂芳基取代的吲哚类化合物
CA2654026A1 (en) 2006-06-08 2007-12-13 Neurokey A/S Use of cannabinoid receptor agonists as hypothermia inducing drugs for the treatment of ischemia
KR20090023645A (ko) 2006-06-28 2009-03-05 사노피-아벤티스 신규한 cxcr2 억제제

Similar Documents

Publication Publication Date Title
NO2020027I1 (no) glasdegib, eventuelt i form av et farmasøytisk akseptabelt salt, inkludert maleatsaltet
CY2016040I1 (el) Επιλογες θεραπειας για τη νοσο του fabry
IS2722B (is) 1, 2, 3, 4- Tetrasetin indól til meðhöndlunar á öndunarfærasjúkdómum
EP1948298A4 (en) BIO-INTERVENING THERAPEUTIC TREATMENT FOR HEART DISEASE DISEASES
PL1993985T3 (pl) Sposób wytwarzania 1,2-propanodiolu
NO343834B1 (no) Farmasøytisk preparat omfattende en omega-karboksylarylsubstituert difenylurea for behandling av cancer
IL233925A0 (en) Pharmaceutical dose for oral administration in the form of tiny particles to prevent incorrect use
JP2009039101A5 (https=)
IL190338A0 (en) Biphenyloxyacetic acid derivatives for the treatment of respiratory disease
IL184456A0 (en) Dosage form for treating gastrointestinal disorders
JP2010525055A5 (https=)
JP2007525988A5 (https=)
JP2007520565A5 (https=)
GB0410399D0 (en) The treatment of respiratory disease
JP2008526936A5 (https=)
IL178815A0 (en) The treatment of respiratory disease
IL185444A0 (en) Novel drugs for treating respiratory diseases
JP2008519810A5 (https=)
PL2366393T3 (pl) Roflumilast do leczenia nadciśnienia płucnego
GB0400802D0 (en) Compounds for the treatment of disease
IL182353A0 (en) Methods using glycosaminoglycans for the treatment of kidney disease
ATE454386T1 (de) Neue indolizinderivate, verfahren zu deren herstellung und therapeutische zusammensetzungen, die diese enthalten
CL2007002565A1 (es) Proceso para preparar 2-cloro-5-(3-oxopropil)-n-(triciclo(3.3.1.1)dec-1-ilmetil)-benzamida.
RU2005128615A (ru) Средство для лечения заболеваний пародонта
JP2007151536A5 (https=)